Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
293,061,432
-
Number of holders
-
126
-
Total 13F shares, excl. options
-
113,127,329
-
Shares change
-
-1,221,415
-
Total reported value, excl. options
-
$1,100,172,856
-
Value change
-
-$30,931,776
-
Put/Call ratio
-
31%
-
Number of buys
-
67
-
Number of sells
-
54
-
Price
-
$9.75
Institutional Holders of AbCellera Biologics Inc. - Ordinary Shares (ABCL) as of Q1 2022
As of 31 Mar 2022 AbCellera Biologics Inc. - Ordinary Shares (ABCL) had 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 113,127,329 shares of stock of the company.
Largest 10 holders included Capital World Investors, Allianz Asset Management GmbH, BAILLIE GIFFORD & CO, BAKER BROS. ADVISORS LP, SB Management Ltd, DCVC Bio GP, LLC, ORBIMED ADVISORS LLC, HARVARD MANAGEMENT CO INC, GUARDIAN CAPITAL ADVISORS LP, and Founders Fund VII Management, LLC.
This table shows 126 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.